Dobutamine-induced high cardiac index did not prevent vasospasm in subarachnoid hemorrhage patients: A randomized controlled pilot study

Neurocritical Care

Volumn 17, Issue 2, 2012, Pages 183-190

  Rondeau, Nelly ^a   Cinotti, Raphaël ^a   Rozec, Bertrand ^a,b   Roquilly, Antoine ^c,d   Floch, Hervé ^e   Groleau, Nicolas ^a   Michel, Patrick ^a   Asehnoune, Karim ^c,d   Blanloeil, Yvonnick ^a  

^a CHU de Nantes   (France)

^b L INSTITUT DU THORAX   (France)

^c HÔTEL DIEU   (France)

^d UNIVERSITÉ DE NANTES   (France)

^e SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Catecholamine; Dobutamine; Neuro intensive care; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

CATECHOLAMINE; DOBUTAMINE; MANNITOL; NORADRENALIN;

ARTICLE; ARTIFICIAL VENTILATION; BRAIN ANGIOGRAPHY; BRAIN ARTERY ANEURYSM; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN VASOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; GLASGOW COMA SCALE; HEART INDEX; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; LENGTH OF STAY; MALE; MEAN ARTERIAL PRESSURE; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SUBARACHNOID HEMORRHAGE;

ADULT; ARTERIAL PRESSURE; BRAIN; DOBUTAMINE; FEMALE; HUMANS; HYPERTENSION; LENGTH OF STAY; MALE; MIDDLE AGED; NOREPINEPHRINE; PILOT PROJECTS; RESPIRATION, ARTIFICIAL; SINGLE-BLIND METHOD; SUBARACHNOID HEMORRHAGE; SYMPATHOMIMETICS; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

EID: 84869234552     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-012-9732-y     Document Type: Article

References (29)

1. Bederson JB, Connolly ES, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40(3):994-1025.
2. Dodel R, Winter Y, Ringel F, et al. Cost of illness in subarachnoid hemorrhage: a German longitudinal study. Stroke. 2010; 41(12):2918-23.
3. Firlik AD, Kaufmann AM, Wechsler LR, Firlik KS, Fukui MB, Yonas H. Quantitative cerebral blood flow determinations in acute ischemic stroke. Relationship to computed tomography and angiography. Stroke. 1997;28(11):2208-13. (Pubitemid 27497924)
4. Awad IA, Carter LP, Spetzler RF, Medina M, Williams FC. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke. 1987;18(2):365-72. (Pubitemid 17059661)
5. Muench E, Horn P, Bauhuf C, et al. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med. 2007;35(8):1844-51; quiz 1852. (Pubitemid 47220357)
6. Naval NS, Stevens RD, Mirski MA, Bhardwaj A. Controversies in the management of aneurysmal subarachnoid hemorrhage. Crit Care Med. 2006;34(2):511-24. (Pubitemid 43149035)
7. Joseph M, Ziadi S, Nates J, Dannenbaum M, Malkoff M. Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: a study using xenon computed tomographic measurement of cerebral blood flow. Neurosurgery. 2003;53(5):1044-51; discussion 1051-2.
8. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, et al. Guidelines for the management of severe traumatic brain injury. VIII. Intracranial pressure thresholds. J Neurotrauma. 2007;24(Suppl 1):S55-8.
9. Beydon L. Severe subarachnoid haemorrhage. Ann Fr Anesth Reanim. 2005;24(7):713-4. (Pubitemid 40942075)
10. Vergouwen MDI, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41(10):2391-5.
11. Clark JF, Sharp FR. Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2006;26(10):1223-33. (Pubitemid 44435238)
12. Sarrafzadeh AS, Haux D, Lüdemann L, et al. Cerebral ischemia in aneurysmal subarachnoid hemorrhage: a correlative microdialysis- PET study. Stroke. 2004;35(3):638-43. (Pubitemid 38280833)
13. Vajkoczy P, Horn P, Thome C, Munch E, Schmiedek P. Regional cerebral blood flow monitoring in the diagnosis of delayed ischemia following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003;98(6):1227-34. (Pubitemid 36617926)
14. Berré J, Gabrillargues J, Audibert G, et al. Vasospasm after severe subarachnoid haemorrhage: diagnosis and treatment. Ann Fr Anesth Reanim. 2005;24(7):761-74. (Pubitemid 40942085)
15. Muizelaar JP, Becker DP. Induced hypertension for the treatment of cerebral ischemia after subarachnoid hemorrhage. Direct effect on cerebral blood flow. Surg Neurol. 1986;25(4):317-25. (Pubitemid 16152723)
16. Yamakami I, Isobe K, Yamaura A. Effects of intravascular volume expansion on cerebral blood flow in patients with ruptured cerebral aneurysms. Neurosurgery. 1987;21(3):303-9. (Pubitemid 17135695)
17. Treggiari MM, Walder B, Suter PM, Romand J-A. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg. 2003;98(5): 978-84. (Pubitemid 36460888)
18. Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest. 2008;134(1):172-8.
19. Michard F, Boussat S, Chemla D, et al. Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med. 2000;162(1):134-8. (Pubitemid 30469810)
20. Lad SP, Guzman R, Kelly ME, et al. Cerebral perfusion imaging in vasospasm. Neurosurg Focus. 2006;21(3):E7.
21. Papanikolaou J, Makris D, Karakitsos D, et al. Cardiac and central vascular functional alterations in the acute phase of aneurysmal subarachnoid hemorrhage. Crit Care Med. 2012;40(1):223-32.
22. Naidech AM. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation. 2005;112(18):2851-6. (Pubitemid 41641680)
23. Kassell NF, Kongable GL, Torner JC, Adams HP, Mazuz H. Delay in referral of patients with ruptured aneurysms to neurosurgical attention. Stroke. 1985;16(4):587-90. (Pubitemid 15007229)
24. Heros RC, Zervas NT, Varsos V. Cerebral vasospasm after subarachnoid hemorrhage: an update. Ann Neurol. 1983;14(6): 599-608. (Pubitemid 14211605)
25. Al-Tamimi YZ, Orsi NM, Quinn AC, Homer-Vanniasinkam S, Ross SA. A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology. World Neurosurg. 2010;73(6):654-67.
26. Weir BK, Kongable GL, Kassell NF, Schultz JR, Truskowski LL, Sigrest A. Cigarette smoking as a cause of aneurysmal subarachnoid hemorrhage and risk for vasospasm: a report of the Cooperative Aneurysm Study. J Neurosurg. 1998;89(3):405-11. (Pubitemid 28405254)
27. Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger H-J. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Neurosurgery. 2006;58(6):1054-65; discussion 1054-65.
28. Lynch JR, Wang H, McGirt MJ, et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke. 2005;36(9):2024-6. (Pubitemid 41266547)
29. Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL. Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab. 2011;31(6):1443-51.